OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging vaccine strategies against the incessant pneumococcal disease
Jeremy A. Duke, Fikri Y. Avci
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Streptococcus pneumoniae epidemiology, pathogenesis and control
Ana Rita Narciso, Rebecca S. Dookie, Priyanka Nannapaneni, et al.
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 10

Streptococcus pneumoniae serotype distribution in low- and middle-income countries of South Asia: Do we need to revisit the pneumococcal vaccine strategy?
Priya Dhawale, Sanket Shah, Kaushal Sharma, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 1

Otitis media: recent advances in otitis media vaccine development and model systems
Ayesha Zahid, Jennifer C. Wilson, I. Darren Grice, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 8

State of pneumococcal vaccine immunity
Mustafa Akkoyunlu
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 6

Community acquired pneumonia due to antibiotic resistant-Streptococcus pneumoniae: diagnosis, management and prevention
Grace Lui, Christopher K.C. Lai
Current Opinion in Pulmonary Medicine (2025)
Closed Access

The Evolution of Pneumococcal Vaccine and Vaccine Schedule in the USA: A Narrative Review of the Last Two Decades (2003-2023)
Queen L Ekpa, Kelechukwu P Oranu, Okelue E Okobi, et al.
World Journal of Vaccines (2025) Vol. 15, Iss. 01, pp. 1-19
Open Access

Pediatric Pleural Effusion and Pneumococcal Vaccination Trends in the Pre- and Post-COVID Era: A Single-Centre Retrospective Study
Doina Atanasiu, Maria Mitrică, L Petrescu, et al.
Children (2025) Vol. 12, Iss. 2, pp. 242-242
Open Access

Critical Quality Attributes and Manufacturing Techniques for Streptococcus pneumoniae Capsular Polysaccharide in Pneumococcal Vaccines: A Review
Yuelong Li, Xueting Huang, Qian Jin, et al.
Carbohydrate Polymer Technologies and Applications (2025), pp. 100733-100733
Open Access

Future immunisation strategies to prevent Streptococcus pneumoniae infections in children and adults
Bernice Ramos, Nirma Khatri Vadlamudi, Crystal Han, et al.
The Lancet Infectious Diseases (2025)
Closed Access

A narrative review on the effectiveness of PPSV23 vaccination in adults in China
Weiyan Zhang, Peng Bai, Weijun Hu
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access

Knowledge, attitudes, and beliefs of pharmacists regarding vaccinations against influenza and pneumococci – a systematic review
Michał Waszkiewicz, Katarzyna Wnuk, Jakub Świtalski, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access

Pneumococcal Surface Proteins as Targets for Next-Generation Vaccines: Addressing the Challenges of Serotype Variation
Sangeetha Gopalakrishnan, Premkumar Jayapal, James John
Diagnostic Microbiology and Infectious Disease (2025), pp. 116870-116870
Closed Access

Splenic red pulp macrophages eliminate the liver-resistantStreptococcus pneumoniaeduring bloodstream infection
Yijia Huang, Zhifeng Zhao, Kunpeng Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3

Impact of Difluoromethylornithine and AMXT 1501 on Gene Expression and Capsule Regulation in Streptococcus pneumoniae
Moses B. Ayoola, Leslie A. Shack, Otto Phanstiel, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 178-178
Open Access | Times Cited: 2

Pilus of Streptococcus pneumoniae: structure, function and vaccine potential
Chenglin Miao, Yali Cui, Ziyi Yan, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 5

Nanoparticles as Delivery Systems for Antigenic Saccharides: From Conjugation Chemistry to Vaccine Design
Marie-Jeanne Archambault, Laetitia Mwadi Tshibwabwa, Mélanie Côté‐Cyr, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1290-1290
Open Access | Times Cited: 1

Antenatal tetanus, diphtheria, and acellular pertussis (Tdap) immunization and risk of serogroup 19 IPD in children: An indirect cohort study
Mélina Thibault, Geneviève Deceuninck, Caroline Quach, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access

Effect of O‐acetylation on the antigenicity and glycoconjugate immunogenicity of the Streptococcus pneumoniae serotype 7F capsular polysaccharide
Jean Pierre Soubal, Aloyma Lugo, Darielys Santana-Mederos, et al.
ChemBioChem (2024) Vol. 26, Iss. 1
Closed Access

LEUKOCYE PHAGOCYTIC ACTIVITY AND NTB TEST IN PATIENTS WITH RHEUMATOID ARTRITIS DURING VACCINATION WITH PNEUMOCOCCAL VACCINE
Б Ц Батожаргалова, М. П. Костинов, I. V. Bisheva, et al.
Russian Journal of Infection and Immunity (2024)
Open Access

Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections
Kimberly Cardoso, Lara Regina Alves de Souza, Beatriz Senra Álvares da Silva Santos, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top